ϩ (KATP) channels in aortic smooth muscle cells (ASMCs) from isoproterenol-induced hypertrophied rabbits. The amplitude of KATP channels induced by the KATP channel opener pinacidil (10 M) was greater in ASMCs from control than from hypertrophied animals. In phenylephrine-preconstricted aortic rings, pinacidil induced relaxation in a dose-dependent manner. The dosedependent curve was shifted to the right in the hypertrophied (EC50: 17.80 Ϯ 3.28 M) compared with the control model (EC50: 6.69 Ϯ 2.40 M). Although the level of Kir6.2 subtype expression did not differ between ASMCs from the control and hypertrophied models, those of the Kir6.1 and SUR2B subtypes were decreased in the hypertrophied model. Application of the calcitonin-gene related peptide (100 nM) and adenylyl cyclase activator forskolin (10 M), which activates protein kinase A (PKA) and consequently KATP channels, induced a KATP current in both control and hypertrophied animals; however, the K ATP current amplitude did not differ between the two groups. Furthermore, PKA expression was not altered between the control and hypertrophied animals. These results suggests that the decreased K ATP current amplitude and KATP channel-induced vasorelaxation in the hypertrophied animals were attributable to the reduction in KATP channel expression but not to changes in the intracellular signaling mechanism that activates the KATP current.
CARDIAC HYPERTROPHY, which is considered to be an active adaptation mechanism to excessive stress, results in increased ventricular wall thickness, frequently concomitant with a high incidence of heart failure (23, 38) . Despite intensive study of the macroscopic and molecular changes in the hearts and coronary/aortic vessels during hypertrophy, knowledge of the alterations in ion channels in the coronary/aortic arteries is limited.
Four types of K ϩ channels have been identified in vascular smooth muscle, including voltage-dependent K ϩ (K V ), inward rectifier K ϩ (Kir), Ca 2ϩ -activated K ϩ (BK Ca ), and ATP-sensitive K ϩ (K ATP ) channel (32, 43) . Of these, K ATP channels are known to regulate the resting membrane potential and, consequently, vascular basal tone (2, 39, 49) . The opening of vascular K ATP channels induces membrane hyperpolarization, leading to vasodilation by closing voltage-dependent Ca 2ϩ channels. Therefore, several studies (10, 15, 22, 31, 39, 45, 54) have focused on the modulation of K ATP channels by vasoactive substances and the functional/structural modification of these channels in pathological conditions such as hypertension and diabetes. However, few studies have focused on functional alterations of K ATP channels during cardiac hypertrophy.
To date, several hypertrophy models have been developed for pathological and physiological studies, including the left ventricular pressure overload model (3, 33) , the right ventricular hypertrophy model (23, 41) , the hypertrophy model concomitant with hypertension (11, 53, 56) , and the catecholamine [isoproterenol (Iso)]-induced hypertrophy model (1, 12, 48) . We (16, 17, 37) previously demonstrated the functional modification of vascular K V , BK Ca , and Kir channels during cardiac hypertrophy, induced by daily Iso injections (16, 17, 37) . In the present study, we tested for the first time the hypothesis that Iso-induced hypertrophy alters K ATP channel expression, which induces functional changes in K ATP channels in aortic smooth muscle. Furthermore, we evaluated the signaling pathways related to K ATP channel impairment during hypertrophy using the patch-clamp technique, Western blotting, and arterial dilation/contraction experiments.
MATERIALS AND METHODS
Induction of cardiac hypertrophy. Rabbit use was approved by the Institutional Animal Care and Use Committee of the University of Inje, Korea. Male New Zealand white rabbits were purchased from Samtako Bio Korea (Osan, Korea). Cardiac hypertrophy was induced by daily Iso injection (300 g/kg body wt iv) for 7 days. The successful induction of cardiac hypertrophy was well established in previous reports (16 -18, 37) and is also shown in Table 1 . Only those test animals proven to exhibit cardiac hypertrophy were used.
Cell preparation. Rabbits (2.0 -2.5 kg) were overdosed with sodium pentobarbitone (50 mg/kg) and simultaneously injected with heparin (100 U/kg) into the ear vein. The hearts were removed immediately after exsanguination and immersed in ice-cold normal Tyrode's solution. The aortic arteries were dissected out and cleaned of blood and surrounding tissues. All arteries were cut open along their longitudinal axes, and cleaned of endothelium. The arteries were transferred to 1 ml of Ca 2ϩ -free normal Tyrode's solution containing papain (1.0 mg/ml), BSA (1.5 mg/ml), and dithiothreitol (DTT; 1.0 mg/ml). After incubation for 25 min at 37°C, the solution was replaced with 1 ml of Ca 2ϩ -free normal Tyrode's solution containing collagenase (2.8 mg/ml), BSA, and DTT and then incubated for 22 min at 37°C. The digested tissues were agitated gently to disperse single cells with a fire-polished Pasture pipette in Kraft-Brühe (KB) medium. Isolated cells were stored in KB solution at 4°C. The cells were studied between 1 and 10 h after isolation.
Vessel preparation and measurement. Control and hypertrophied rabbit aortic arteries were isolated, freed from surrounding tissue, and cut into rings 10 mm in length under physiological salt solution (PSS). The endothelium was disrupted by perfusing an air bolus into the vessel lumen, and then the rings were mounted onto two stainless steel stirrups and placed into an organ chamber containing continuously oxygenated (95% O 2-5% CO2) PSS at 37°C and pH 7.4. One stirrup was mounted on a stable hook, while the other was connected to a strain gauge. The arteries were adjusted to a resting tension of 1 g over a period of 60 min. Successful removal of the endothelium was verified by the response to acetylcholine (1 M).
Solutions and chemicals. Normal Tyrode's solution contained the following (in mM): 13 NaCl, 5. All pharmacological compounds were dissolved in distilled water or DMSO to make stock solutions. Pinacidil, levcromakalim, calcitonin-gene related peptide (CGRP), and glibenclamide were purchased from Sigma Chemical (St. Louis, MO). Forskolin was obtained from Tocris Cookson (Ellisville, MO).
Electrophysiology. Whole cell patch-clamp recordings were performed using an Axon interface and Axopatch 1C amplifier (Axon Instruments, Union, CA). Pulse generation and data acquisition were controlled using PatchPro software, which was developed by our group. Patch pipettes were pulled from borosilicate capillaries (Clark Electromedical Instruments, Pangbourne, UK) using a PP-83 vertical puller (Narishige Scientific Instrument Laboratory, Tokyo, Japan). The voltage and current signals were filtered at 0.5ϳ1.0 kHz and sampled at a rate of 1ϳ3 kHz. Electrode resistance was maintained at 3-4 M⍀.
Western blotting. To prepare membrane fractions, endotheliumdenuded aorta was homogenized in buffer A (20 mM Tris·HCl, 150 mM NaCl, 10 mM EDTA, 50 mM NaF, 25 mM NaVO 4, and proteinase inhibitor) and centrifuged at 12,000 rpm for 2 min. The resulting supernatant was subjected to a second centrifugation at 100,000 rpm for 45 min to precipitate the plasma membrane fraction. The final pellet was homogenized in buffer B (20 mM Tris·HCl, 150 mM NaCl, 10 mM EDTA, 50 mM NaF, 25 mM NaVO 4, and 1% Triton X-100).
Protein (50 g) was subjected to 10% SDS-PAGE and then transferred to nitrocellulose membranes (Amersham Bioscience,). The blocked membrane was then incubated with antibodies against Kir6.1, Kir6.2, SUR-2B, and PKA (Santa Cruz Biotechnology,). Immunoreactive bands were visualized using a SuperSignal West Dura Extended Duration Substrate kit (Pierce Chemical).
Immunohistochemistry. The aortas were isolated from control and Iso-treated rabbits and washed with PBS twice to remove blood. Aortas were fixed by 4% formaldehyde in PBS for 24 h. For making frozen block, they were put into the mold and filled by optimal cutting temperature compound (Sakura Finetek, Torrance, CA). The molds were immediately put into liquid nitrogen. Frozen tissues were sectioned by cryostat microtome (Leica, Nussloch, Germany) for immunohistochemistry. The slides were rinsed three times in PBS in 5 min and then were blocked by CAS-Block (Invitrogen, Frederick, MD) for 1 h and then were applied Kir6.1-, Kir6.2-, SUR2B-, and PKA␣/␤-primary antibody at 4°C for overnight. The slides were rinsed three times by PBS for 10 min, and then they were applied Alexa Fluor 594 (Invitrogen) at 37°C for 1 h. The slides were rinsed three times by PBS for 10 min, and then they were covered with Prolong Gold Values are means Ϯ SE; [n] ϭ number of animals; (n) ϭ number of cells. *P Ͻ 0.05. Fig. 1 . Whole cell KATP currents induced by pinacidil in the control and hypertrophied models. Whole cell KATP currents were recorded from a holding potential of Ϫ60 mV, showing pinacidil activation of glibenclamide-sensitive K ϩ currents in the control (A) and hypertrophied (B) models. C: current density of KATP channels in the control and hypertrophied models. Current was normalized for cell capacitance (pF). *P Ͻ 0.05; n ϭ 6.
antifade reagent with DAPI (Invitrogen). Fluorescent images were observed and analyzed under a Zeiss 700 Laser-scanning confocal microscope (Zeiss, Göettingen, Germany).
Statistics. Origin 6.0 software (Microcal Software, Northampton, MA) was used for data analysis. The data are expressed as means Ϯ SE. The statistical significance of differences was evaluated using unpaired Student's t-tests. P Ͻ 0.05 was considered significant. Figure 1 shows the K ATP currents recorded from the aortic smooth muscle cells (ASMCs) of the control and hypertrophied animals. To optimize the recordings, whole cell recordings were performed in symmetrical 140 mM K ϩ , with the cells clamped at a holding potential of Ϫ60 mV. Furthermore, 10 mM BAPTA, a Ca 2ϩ chelator, was added to the pipette solution. These recording conditions minimized Ca 2ϩ -activated and voltage-dependent K ϩ currents. Raising the extracellular K ϩ to 140 mM induced small K ATP currents. To enhance the K ATP currents, we applied the synthetic K ATP channel opener pinacidil (10 M). Figure 1 , A and B, shows the pinacidil-induced K ATP currents in ASMCs from both the control and hypertrophied models. The amplitude of the control K ATP current was greater than that of the hypertrophied model (Ϫ10.92 Ϯ 0.97 pA/pF in the control and Ϫ7.14 Ϯ 0.83 pA/pF in the hypertrophied model; Fig. 1C ). The currents were completely inhibited by the sulfonylurea K ATP channel inhibitor glibenclamide (10 M).
RESULTS

Comparison of K ATP currents between control and hypertrophied animals.
Effect of pinacidil on phenylephrine-preconstricted aortic rings. To further demonstrate the reduction in K ATP channel density, we compared the pinacidil-induced relaxation in phenylephrine (Phe)-preconstricted aortic rings isolated from control and hypertrophied animals. As shown in Fig. 2, A and B , pinacidil-induced vasorelaxation was greater in the control than in the hypertrophied model. The dose-response curve was shifted to the right in the hypertrophied model compared with the control (EC 50 : 6.69 Ϯ 2.40 M in the control, EC 50 : 17.80 Ϯ 3.28 M in the hypertrophied model; Fig. 2C) . In addition, we tested the effect of the K ATP channel opener pinacidil on the vasodilatory response to the basal tone between the control and hypertrophied models. As shown in Fig. 2, D and E, pinacidilinduced vasodilation was greater in the control than in the hypertrophied model (Fig. 2F , control: Ϫ22.62 Ϯ 2.24%, hypertrophy: Ϫ14.35 Ϯ 1.05%; 40 mM K ϩ -induced vasoconstriction were regarded as ϩ100% vasoconstriction). There were no differences in EC 50 between the endothelium-intact and -denuded aortic preparations.
K ATP channel expression in the control and hypertrophied models. To determine the decrease in K ATP channel density and the reduction in K ATP channel-induced vasoreactivity in the hypertrophied model, we performed Western blotting and immunohistochemistry using specific antibodies against Kir6.1, Kir6.2, and SUR2B. This is because the K ATP channel subunits predominantly expressed in native vascular smooth muscle are Kir6.1/6.2 and SUR2B (7, 52) . Figure 3 showed that the expression levels of Kir6.1 (37.7% reduction; Fig. 3, A and B) and SUR2B (41.8% reduction; Fig. 3 , G and H) were dramatically decreased in the hypertrophied model, and confirming immunohistochemistry data also showed the decrease in expression level of Kir6.1 and SUR2B (Fig. 3, C and I) ; however, that of Kir6.2 was unchanged (Fig. 3, D and F) . These results suggest that the reductions in K ATP current and K ATP channelmediated vasoreactivity in the hypertrophied model were attributable to reduced K ATP channel expression.
Effect of another K ATP channel activator, levcromakalim on K ATP current and Phe-preconstricted aortic rings. To further evaluate the reduction in K ATP channel expression in the hypertrophied model, we used another K ATP channel opener, levcromakalim (10 M), to confirm the above findings (Figs. 1  and 2 ). The addition of levcromakalim activated the K ATP current in both the control and hypertrophied models (Fig. 4, A  and B) , with the resulting current being higher in the control than in the hypertrophied model (Ϫ12.91 Ϯ 0.92 pA/pF in the control and Ϫ8.19 Ϯ 1.26 pA/pF in the hypertrophied model; Fig. 4C ). In addition, the levcromakalim-induced vasorelaxation in Phe-preconstricted aortic rings was greater in the control than in the hypertrophied model (74.22 Ϯ 2.28 relaxations in the control and 55.95 Ϯ 1.91 relaxations in the hypertrophied model; Fig. 4, D-F) .
Comparison of CGRP and forskolin-induced K ATP currents in ASMCs from control and hypertrophied animals. K ATP channels activation is closely related to the activation of adenylyl cyclase, which leads to increased cAMP and PKA Fig. 3 activation (50) . To test the impairment of K ATP channel-related signaling mechanisms, we applied the CGRP (100 nM) and adenylyl cyclase activator forskolin (10 M) to ASMCs from control and hypertrophied animals. CGRP has been ascribed to a potent vasodilator in the coronary vessels and an effective activator of K ATP channel by increase of cAMP and PKA (50) . Figure 5 , A and B, showed that the CGRP-induced K ATP current activation did not differ between ASMCs from the control and hypertrophied models (Ϫ4.49 Ϯ 0.65 pA/pF in the control and Ϫ5.02 Ϯ 0.61 pA/pF in the hypertrophied model; Fig. 5C ). Furthermore, as shown in Fig. 5, D and E, the K ATP channel activation level induced by adenylyl cyclase activator forskolin was not significantly different between ASMCs from the control and hypertrophied models (Ϫ3.94 Ϯ 0.33 pA/pF in the control and Ϫ3.75 Ϯ 0.29 pA/pF in the hypertrophied model; Fig. 5F ). To further evaluate the alteration in K ATP channel-related signaling, we performed Western blots and immunohistochemistry on homogenized arterial tissues using a PKA-specific antibody. Figure 6 shows that PKA expression level was similar in aortic tissues from control and hypertrophied animals. These results suggest that the decreased K ATP channel density and reduced K ATP channel-induced vasoreactivity in the hypertrophied model were not caused by a K ATP channel-related signaling mechanism but by a decrease in K ATP channel expression.
DISCUSSION
In the present study, we demonstrated a decrease in K ATP channel density and a reduction in K ATP channel-induced vasoreactivity in the hypertrophied model owing to a reduction in K ATP channel expression, rather than an alteration in K ATP channel-related signaling.
To date, several hypertrophy models have been developed and used in various physiological/pharmacological studies. Of these, catecholamine (Iso)-induced hypertrophy is regarded as Fig. 4 . Effect of levcromakalim on the KATP current and KATP channel-induced relaxation in aorta from control and hypertrophied animals. Levcromakalim-induced activation of the KATP current in aortic smooth muscle cells (ASMCs) from control (A) and hypertrophied (B) animals. C: current density of KATP channels in control and hypertrophied animals. Current was normalized for cell capacitance (pF). *P Ͻ 0.05; n ϭ 5. Experimental records show the effect of levcromakalim on Phe-induced precontraction in aorta isolated from control (D) and hypertrophied (E) animals. F: summary of the effects of levcromakalim on vasodilation. *P Ͻ 0.05; n ϭ 4. a simple, but well-established model. We previously demonstrated that the daily injection of Iso for 7 days increased the heart weight by 18% but did not alter the liver or lung weight (37) . Furthermore, the cell capacitance of ventricular myocytes was increased by 13%. Blood pressure was also mildly increased but not to a level resulting in heart failure, suggesting that this model represents mild hypertrophy.
K ATP channels have been identified in various tissues, including vascular smooth muscle (32) . K ATP channels expressed in vascular smooth muscle play a crucial role in maintenance of the vascular resting tone by regulating the resting membrane potential and local blood flow, consequently, blood pressure (36, 40, 44) . Vascular K ATP channel impairment has been reported in several cardiovascular disease models, including hypertension, diabetes, and obesity. Although most studies agree with the impairment of K ATP channels in stroke-prone spontaneously hypertensive rats (21, 35, 45) and DOCA slat-induced hypertension (10), the exact mechanism of K ATP channel impairment remains controversial. Furthermore, some contrary studies (the vasorelaxant effect of K ATP channel openers or K ATP channel expression was greater in stroke-prone spontaneously hypertensive rats; Refs. 9, 19, 24, 34) make it difficult to understand the changes in K ATP channels during hypertension. Under diabetic conditions, several reports have suggested that the vasodilatory response to a K ATP channel opener was diminished by vascular endothelium dysfunction (8, 28, 54) . Exposure to a high glucose concentration also impaired vascular K ATP channel function through a high glucose-induced increase in superoxide production (20) . Although the mechanisms are obscure, obesity induced by a high-fat diet also impairs the K ATP channels (5, 6) . In the present study, we first demonstrated the impairment of vascular K ATP channel function during cardiac hypertrophy. Considering the relevance of vascular K ATP channels to the regulation of aortic tone, this information will facilitate an increased understanding of the pathological and physiological alterations of the aorta during cardiac hypertrophy.
Although most studies of the alterations of ion channels during cardiac hypertrophy were performed using cardiac myocytes, a few have addressed the alteration of vascular ion channels. For example, despite the fact that BK Ca channel activity is believed to be enhanced by hypertension (25, 26) , BK Ca channel activity was reportedly decreased in a hypertrophy model (16) . K V channel activity was diminished under hypertrophic conditions, similar to other cardiovascular diseases (17) . The alteration of Kir channels during hypertension, ischemia, and diabetes are relatively well characterized (27, 29, 30) . However, a unique study of Kir channel alteration during cardiac hypertrophy was performed by our group (37) . Although vascular Ca 2ϩ channels are expected to increase under hypertrophic conditions as in other cardiovascular diseases (51) , to date, there are few reports of the alteration of vascular Ca 2ϩ channels during cardiac hypertrophy.
Several signaling pathways regulate K ATP channels in vascular smooth muscle cells and well as other cell types. The regulation of the K ATP channel by PKA and PKC has been extensively studied in vascular smooth muscle; however, other protein phosphatases have not been investigated to the same extent (46) . The K ATP channels expressed in vascular smooth muscle are actively responsive to many vasodilators, which activate adenylyl cyclase, thereby increasing the intracellular cAMP level and activating PKA (43) . Therefore, the reduced K ATP channel activity during cardiac hypertrophy may alter PKA-related signal transduction. However, our data indicate that the K ATP current amplitude induced by the CGRP and adenylyl cyclase activator forskolin did not differ in control and hypertrophied animals. Furthermore, the levels of PKA expression were similar in the control and hypertrophied animals. Therefore, our results suggest that the reduced K ATP current and K ATP channel-induced vasodilation in the hypertrophied model were independent of K ATP channel-related signaling.
The A-kinase anchoring proteins (AKAPs) are involved in the specificity of PKA phosphorylation and PKA localization (4, 42) . Recently, AKAP has been reported to be involved in the PKA activity essential for the regulation of arterial K ATP channels (13) . The detailed mechanism by which AKAP regulates the interaction between PKA and K ATP channels in the vascular smooth muscle cells, however, remains to be determined (42) . Among the AKAP subtypes, AKAP12 (gravin) was reported to have a specific binding domain for the ␤ 2 -adrenergic receptor (47) . Therefore, AKAP12 expressed in vascular smooth muscle could be related to vascular function and ion channels, but direct evidence for such regulations is still to be elucidated.
PKG is an important factor in the regulation of the basal tone in the vascular system; it is regulated by NO, synthesized, and released from intact endothelial cells. Interestingly, PKG inhibitors or NO (produced by sodium nitroprusside) did not show any significant effect on the glibenclamide-sensitive K ATP current in the study of CGRP-induced activation of K ATP channels (50) .
The signaling pathway through PLC or IP 3 is one of the most important mechanisms of vasoconstriction. They regulate the intracellular free Ca 2ϩ concentration by affecting voltage-dependent Ca 2ϩ channel and/or intracellular Ca 2ϩ storage (55) . Previous studies (14) suggested that angiotensin II binds to G protein coupled receptors activating PLC and DAG leading to the activation of PKC, consequently inhibits the K ATP channel. Similar to angiotensin II, many other vasoconstrictors also inhibits the K ATP channel via PKC pathway (46) . In a previous report (37), we clearly showed alternation of the PKC pathway in the hypertrophied model for angiotensin II-induced regulation of Kir channels. Although our study mainly focused on alteration of PKAinduced vasodilation during hypertrophy, a study for alteration of vascular K ATP channels via PKC activity using this hypertrophied model is necessary in the near future. In this study, we first demonstrated the alteration of vascular K ATP channels during hypertrophy. The functional and electrophysiological defects in K ATP channel activity limit arterial constriction, which induces an increase in blood pressure, possibly contributing to the development of cardiac hypertrophy. 
GRANTS
